Skip to NavigationSkip to content

Pharmafile - Research and Development

One in four people worldwide will be obese by 2045 if current trends continue, the possible cause of the most common childhood cancer has been...
AstraZeneca's immunotherapy Imfinzi met its second primary endpoint in the treatment of unresectable Stage III non-small cell lung cancer in...
MSD Keytruda has enjoyed the most success of the PD-1/L1 therapies in clinical trials recently and it’s rapidly cementing its position as the leader...
The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and an equity investment of...

Features

Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries....

Appointments

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit card for personal purchases, it has...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches